Our first animation! @FusionPharmaInc #radiopharmaceuticals #TAT

Fusion will be presenting at the JPM Healthcare Conference on Thursday at 11am PST! #JPM20 https://t.co/6LhUXXNaOh

Thank you Premier @fordnation for coming to @MIP_Hamilton this afternoon to visit the McMaster Automotive Resource Centre #MARC, Biomedical Engineering and Advanced Manufacturing #BEAM Project Centre and @FusionPharmaInc.

Come see our poster tomorrow at #ASCO2019 !!! A Phase I study of [225Ac]-FPI-1434 radioimmunotherapy in patients with IGF-1R expressing solid tumors. Saturday, June 1, 2019, 8:00 AM-11:00 AM CDT McCormick Place, Hall A

We look forward to presenting our corporate update tomorrow (May 1st) at 11:30am at #BBHIC2019 in Toronto - please stop by! @bloomburton

On Tuesday, I had an opportunity to once again congratulate @FusionPharmaInc on their record $105 USD million investment at the @MIP_Hamilton @McMasterU for research and aid in the development of cancer therapies.

McMaster-based @FusionPharmaInc has received $105M (USD) in private financing to help develop new cancer therapies. Along with being an important step towards helping cancer patients, it's also good news for job creation and innovation in #hamont.

Proud day for @McMasterU & #HamOnt: McMaster spinout @FusionPharmaInc closed $105MM SeriesB round, largest private investment into a biotech company in Canada. Fusion does amazing work here at @MIP_Hamilton. An inspiration to all Canadian entrepreneurs. https://t.co/OdyitGTg43

Pleased to meet Minister @DrFullertonMPP this morning at the announcement of $100M USD in private financing for @FusionPharmaInc ⚛ helping to develop new cancer treatments here @mip_hamilton This is a huge success for @hamiltonecdev @McMasterU & #HamOnt

Today at MIP, @FusionPharmaInc announced that they are the recipients of the largest single investment in the history of Canadian startups. Check out the video for the full story: https://t.co/VwYaYWYIDc

Congrats to portfolio company @FusionPharmaInc on completing an impressive $105M Series B financing. Proud to help support this #Ontario #biotech grow in their #fightagainstcancer

@VarianMedSys @OrbiMed #PivotalbioVP #PerceptiveAdvisors #RockSpringsCapital @HealthCapVC #AdamsStreetPartners @JNJInnovation #TPGbiotech #SerobaLifeSciences @GenesysCapital @FACITca

Pleased to announce we have closed our Series B of $105 million! These new funds will allow us to advance our clinical and pipeline assets as well as grow the company. Looking forward to working with our new and existing investors! https://t.co/wFWKMObmt3

Actinide #isotopes are not only helping scientists expand the #periodictable, they’re also helping pioneer new #medical treatments. Learn how actinium-225 from ORNL is being used to fight #cancer. 🔗 https://t.co/1yjTps3IJB

ICYMI No one treatment works on all cancers, and even within a single patient, cancer cells can behave differently. New probes that both treat and monitor cancer at the same time open new possibilities for personalized care: https://t.co/qo660z8C3h @McMasterU @FusionPharmaInc

{Featured video} “How can I stop the disease? How can I shut it down? By understanding the molecules and the function of the disease on the inside, you can better select the best treatment for the disease.” https://t.co/00wQECIieR @McMasterU @FusionPharmaInc

Pleased to announce that John Crowley, CPA, has joined as CFO. Welcome John! @FusionPharmaInc https://t.co/PgL5VtAg3P

Pleased to announce our first patient has been dosed with FPI-1434! Thank you to our employees, partners, and patients. Together we are changing the world of #TATs and #cancer treatment. https://t.co/T4Dvn7t9Yx @ENERGY @NSED_ORNL @ORNL @McMasterU @ImmunoGenInc @OICR_news #CPDC

We appreciate your hard work!

Welcome to the world of targeted alpha therapeutics! #radiopharmaceuticals #TAT